In breast cancer, CAF-derived circulating EVs containing the full mitochondrial genome enhance estrogen receptor (ER)-independent oxidative phosphorylation (OXPHOS), which induces therapy-resistant dormant cancer stem-like cells, leading to resistance to endocrine therapy (283). This evidence concerns the gene ESR1 and breast carcinoma.